Trial Profile
Phase I Trial of a Therapeutic DNA Vaccine for Chronic Hepatitis C Virus (HCV) Infection
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2016
Price :
$35
*
At a glance
- Drugs INO 8000 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Biomarker; Pharmacodynamics
- 14 Jul 2016 New trial record